NAMS — NEWAMSTERDAM PHARMA COMPANY
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 210 SEC-registered investment managers reported holding NAMS (NEWAMSTERDAM PHARMA COMPANY) in their latest 13F filings, with a combined reported value of $4.75B across 141.29M shares. That is -7.5% by share count (-10.62M shares) versus the previous quarter, while reported value moved -2.2%. Ownership is concentrated: the five largest holders account for 44.6% of reported value and the top ten for 62.4%.
Compared with the prior quarter, 51 opened new positions, 73 added to existing stakes, 53 trimmed, 23 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of NEWAMSTERDAM PHARMA COMPANY (NAMS) include Frazier Life Sciences Management, L.P., Capital World Investors, RA CAPITAL MANAGEMENT, L.P., ranked by reported 13F value among the 326 institutional holders on this page.
NAMS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding NAMS
The superinvestors we track who report NAMS in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q2 2026 | 4.20M | $142.46M | 0.41% | Hold |
|
|
Q2 2026 | 3.27M | $110.75M | 1.00% | Add |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 119 | 44.21M | $1.07B | +8.9% |
| Q2 2026 | 210 | 141.29M | $4.75B | -7.5% |
| Q1 2026 | 181 | 145.89M | $4.67B | +2.9% |
| Q4 2025 | 195 | 139.30M | $4.88B | -4.9% |
| Q3 2025 | 143 | 142.67M | $4.05B | +4.3% |
| Q2 2025 | 136 | 136.29M | $2.47B | +7.9% |
| Q1 2025 | 129 | 125.35M | $2.57B | +16.9% |
| Q4 2024 | 134 | 108.44M | $2.79B | +20.6% |
Over the 8 quarters shown, institutional share counts decreased 59% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+20.6%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.88M | $313.28M | 0.04% | Add | |
| 12.12M | $294.68M | 0.01% | Add | |
| 2.18M | $53.07M | 41.90% | Reduce | |
| 1.84M | $44.80M | 0.01% | Add | |
| 1.23M | $29.28M | 0.00% | Add | |
| 1.18M | $28.80M | 0.04% | Add | |
| 1.04M | $25.31M | 0.00% | Reduce | |
| 874.57K | $21.27M | 0.02% | Add | |
| 865.40K | $21.05M | 0.01% | Add | |
| 836.58K | $20.35M | 0.00% | Add | |
| 866.53K | $18.14M | 0.00% | Reduce | |
| 702.00K | $17.07M | 0.76% | Hold | |
| 573.19K | $13.94M | 0.23% | Reduce | |
| 547.63K | $13.32M | 0.25% | Add | |
| 373.27K | $9.08M | 0.02% | Add | |
| 357.52K | $8.69M | 0.08% | Add | |
| 337.98K | $8.22M | 0.00% | Reduce | |
| 309.16K | $7.52M | 0.52% | Add | |
| 308.83K | $7.51M | 0.00% | Add | |
| 303.82K | $7.39M | 1.98% | Add | |
| 280.41K | $6.82M | 0.01% | Add | |
| 275.00K | $6.69M | 0.31% | Hold | |
| 225.08K | $5.47M | 0.02% | Reduce | |
| 204.46K | $4.97M | 0.00% | Add | |
| 196.63K | $4.78M | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
Q3 2025 — 25 funds
Q2 2025 — 25 funds
New Positions (Q2 2026)
- Jupiter Topco LLC 2.54M sh · $86.01M
- Orbis Allan Gray Ltd 1.75M sh · $59.23M
- PRICE T ROWE ASSOCIATES INC /MD/ 1.17M sh · $39.56M
- PERCEPTIVE ADVISORS LLC 500.00K sh · $16.95M
- Ikarian Capital, LLC 400.00K sh · $13.56M
- HRT FINANCIAL LP 349.84K sh · $11.86M
- ExodusPoint Capital Management, LP 304.33K sh · $10.31M
- TD ASSET MANAGEMENT INC 148.40K sh · $5.03M
- Jump Financial, LLC 144.51K sh · $4.90M
- KORNITZER CAPITAL MANAGEMENT INC /KS 139.93K sh · $4.74M
- Jefferies Financial Group Inc. 122.73K sh · $4.16M
- D. E. Shaw & Co 120.56K sh · $4.09M
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 2.26M sh · $72.25M
- Logos Global Management LP sold 600.00K sh · $19.21M
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME sold 285.29K sh · $9.13M
- Marshall Wace sold 264.80K sh · $8.48M
- Nicholas Investment Partners, LP sold 125.14K sh · $4.01M
- Catalio Capital Management, LP sold 83.55K sh · $2.67M
- STATE STREET CORP sold 63.09K sh · $2.02M
- Lifetime Wealth Management P.C. sold 23.50K sh · $752.24K
- CenterBook Partners LP sold 22.25K sh · $712.35K
- Legato Capital Management LLC sold 21.57K sh · $690.46K
- DAFNA Capital Management LLC sold 20.00K sh · $640.20K
- Aquatic Capital Management LLC sold 19.63K sh · $628.36K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital World Investors | 12.88M | 12.23M | 11.11M | 9.98M | 9.82M | 8.39M | 6.80M | 1.02M | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 12.12M | 10.34M | 8.77M | 6.41M | 5.54M | 1.90M | 963.82K | 212 | 330.41K | 243.70K | 243.70K | — | — | — | — | — |
| Medicxi Ventures Management (Jersey) Ltd | 2.18M | 2.21M | 2.67M | 2.87M | 2.87M | 2.87M | 2.87M | 2.87M | 2.87M | 2.87M | 2.87M | 2.87M | 2.87M | — | — | — |
| Capital International Investors | 1.84M | 1.72M | 1.44M | 2.06M | 2.06M | 2.06M | 2.06M | 2.06M | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 1.23M | 1.13M | 884.23K | 999.98K | 1.30M | 1.46M | 991.32K | 60.98K | 22.35K | 8.07K | 4.32K | — | 2.62K | 11.46K | 22.37K | 1.10K |
| Aberdeen Group plc | 1.18M | 1.10M | 837.00K | 729.48K | 661.95K | 735.03K | 376.86K | 179.06K | 129.06K | 76.00K | — | — | — | — | — | — |
| BlackRock Inc | 1.04M | 1.06M | 886.62K | 849.78K | 622.51K | 571.67K | 497.98K | 441.52K | 66.67K | — | — | — | — | — | — | — |
| BNP Paribas Asset Management Holding S.A. | 874.57K | 781.14K | 957.44K | 177.02K | — | — | — | — | — | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | 865.40K | 684.81K | 519.46K | 603.40K | 624.28K | 532.92K | 528.83K | 346.57K | — | — | — | — | — | — | — | — |
| Morgan Stanley | 836.58K | 575.83K | 555.76K | 532.80K | 1.50M | 637.71K | 437.54K | 430.10K | 203.21K | 24.69K | 177.59K | 28.54K | 1.70K | 808 | 503 | — |
| Franklin Resources | 866.53K | 993.92K | 770.16K | 769.12K | 405.82K | 334.21K | 255.91K | — | — | — | — | — | — | — | — | — |
| NWI MANAGEMENT LP | 702.00K | 702.00K | 702.00K | 702.00K | — | — | — | — | — | — | — | — | — | — | — | — |
| TimesSquare Capital Management, LLC | 573.19K | 796.16K | 751.99K | 822.30K | 837.37K | 872.54K | 891.09K | 895.57K | 255.25K | 246.09K | 228.62K | — | — | — | — | — |
| KENNEDY CAPITAL MANAGEMENT LLC | 547.63K | 421.37K | 408.49K | 172.93K | 146.72K | 13.68K | — | 7.95K | 14.05K | 11.85K | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 373.27K | 47.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jump Financial, LLC | 357.52K | 144.51K | — | — | — | — | — | 25.40K | — | — | — | — | — | — | — | — |
| BNY Mellon | 337.98K | 353.30K | 378.80K | 391.83K | 333.00K | 352.95K | — | — | — | — | — | — | — | — | — | — |
| Mizuho Markets Cayman LP | 309.16K | 150.54K | 52.23K | 47.88K | — | — | — | — | — | — | — | — | — | — | — | — |
| VICTORY CAPITAL MANAGEMENT INC | 308.83K | 172.66K | 172.66K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Atle Fund Management AB | 303.82K | 248.85K | 94.80K | 197.04K | 193.62K | 157.22K | 107.78K | 138.98K | 138.98K | 75.79K | 22.39K | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold NAMS?
As of 2026-Q2, 210 institutional funds reported holding NAMS (NEWAMSTERDAM PHARMA COMPANY) in SEC 13F filings, with a combined reported value of $4.75B.
How many shares of NAMS do institutions own?
13F filers reported 141.29M shares of NAMS, worth $4.75B in aggregate at the end of 2026-Q2.
Is institutional ownership of NAMS rising or falling?
Share counts moved -7.5% versus the prior quarter — distribution.
Who are the top institutional holders of NAMS?
The largest 13F holders are Frazier Life Sciences Management, L.P., Capital World Investors, RA CAPITAL MANAGEMENT, L.P., Capital World Investors, Fidelity Management & Research (FMR); the top 25 are ranked at the top of this page.
Who are the major shareholders of NEWAMSTERDAM PHARMA COMPANY?
The major shareholders of NEWAMSTERDAM PHARMA COMPANY (NAMS) by reported 13F value are Frazier Life Sciences Management, L.P., Capital World Investors, RA CAPITAL MANAGEMENT, L.P., Capital World Investors, Fidelity Management & Research (FMR), among 326 institutional holders.
Which legendary investors own NAMS?
2 of the legendary investors tracked on HoldingsHub report NAMS (NEWAMSTERDAM PHARMA COMPANY) in their latest 13F filings, led by Viking Global Investors, Lee Ainslie. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on NAMS?
2 tracked superinvestors hold NAMS simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.